Table #47

The 13th WRIB  will be built on the success of the previous meetings, especially the 12th WRIB where over 900 professionals representing pharmaceutical/ biopharmaceutical companies, CROs and multiple regulatory agencies convened to discuss current topics of interest in bioanalysis, biomarkers, and immunogenicity. High quality, better compliance to regulations and scientific excellence are always the foundations of this workshop.

More Conference Information